The better survival and clinical efficacy achieved with pemetrexed/platinum doublets in this study might be explained by the restriction to adenocarcinoma histology, because adenocarcinomas express TS, a key enzymes inhibited by pemetrexed29. Here, TYMS is linked to adenocarcinoma.